Literature DB >> 12763692

The value of vaccines.

Vega Masignani1, Maria Lattanzi, Rino Rappuoli.   

Abstract

Today, we have the technology to make vaccines against most infectious diseases and in theory we could free mankind from most of them. In spite of the great progress of science and technology, vaccines are an endangered species and there are increasing non-technological barriers to their development. Indeed, we have no mechanisms for developing vaccines needed only in developing countries, and in developed countries they are not a priority. Industry is walking away from vaccines and even the existing ones are in jeopardy. The reasons for the low interest in vaccines lie in the high risk and low profitability of the vaccine business. A story about the consequences that an infectious disease had on the economic development of the city of Siena in 1348 is used to show that our society is not calculating the intangible values deriving from vaccination. The failure of assigning the right value to vaccines and preventive medicine is a major risk of today's world that, having the opportunity of improving the proportion of healthy population, may have made the choice of increasing the number of chronically sick people.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12763692     DOI: 10.1016/s0264-410x(03)00209-3

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  4 in total

1.  The Economic Value of Vaccination: Why Prevention is Wealth.

Authors: 
Journal:  J Mark Access Health Policy       Date:  2015-08-12

2.  Drug versus vaccine investment: a modelled comparison of economic incentives.

Authors:  Stéphane A Régnier; Jasper Huels
Journal:  Cost Eff Resour Alloc       Date:  2013-09-08

3.  Cocrystal structure of meningococcal factor H binding protein variant 3 reveals a new crossprotective epitope recognized by human mAb 1E6.

Authors:  Federica Bianchi; Daniele Veggi; Laura Santini; Francesca Buricchi; Erika Bartolini; Paola Lo Surdo; Manuele Martinelli; Oretta Finco; Vega Masignani; Matthew J Bottomley; Domenico Maione; Roberta Cozzi
Journal:  FASEB J       Date:  2019-10-05       Impact factor: 5.191

4.  From population to public institutions: what needs to be changed to benefit from the full value of vaccination.

Authors:  Thomas Szucs; Sibilia Quilici; Marina Panfilo
Journal:  J Mark Access Health Policy       Date:  2015-08-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.